Richard S. Schwartz

Recombinant Factor VIII for the Treatment of Previously Untreated Patients with Hemophilia A -- Safety, Efficacy, and Development of Inhibitors

Jeanne M. Lusher, Steven Arkin, Charles F. Abildgaard et al. · New England Journal of Medicine · 1993 · 494 citations · Full text

Medicine, Hematology, Infectious Diseases +14

Immunomodulatory and Antimicrobial Efficacy of Intravenous Immunoglobulin in Bone Marrow Transplantation

Keith M. Sullivan, Kenneth J. Kopecky, Jane Jocom et al. · New England Journal of Medicine · 1990 · 394 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Human Recombinant DNA–Derived Antihemophilic Factor (Factor VIII) in the Treatment of Hemophilia A

Richard S. Schwartz, Charles F. Abildgaard, Louis M. Aledort et al. · New England Journal of Medicine · 1990 · 266 citations

Medicine, Biotechnology, Hematology +12

Treatment of von Willebrand disease with a high-purity factor VIII/von Willebrand factor concentrate: a prospective, multicenter study

Pier Mannuccio Mannucci, Juan Chediak, Wahid T. Hanna et al. · Blood · 2002 · 192 citations · Full text

Medicine, Hematology, Pathology +13

Recombinant Factor VIII for the Treatment of Previously Untreated Patients with Hemophilia A

Jeanne M. Lusher, Steven Arkin, C. F. ABILGAARD et al. · Survey of Anesthesiology · 1993 · 182 citations

Medicine, Hematology, Hemostasis +12